Latest Articles in pfizer
Pfizer To Extend Covid Vaccine Contract With EU To 2026
The drugmaker has offered to cut the number of doses being supplied by 40 per cent and delay delivery of the shots, the report added. Under the revised terms, Pfizer is asking for payment for doses ordered that will never be manufactured, the FT report said
Read More
Pfizer/Biontech, Moderna Prepare For London Trial 2024
Pfizer and BioNTech sued Moderna in London in September, seeking to revoke two of Moderna's patents in relation to its messenger RNA (mRNA) vaccines.
Read More
Pfizer Predicts Weak 2023 Sales Of Covid Products
The U.S. drugmaker said it expects sales of USD 13.5 billion from the vaccine for 2023, below Refinitiv estimates of USD 14.39 billion, and projected USD 8 billion in sales of its antiviral pill, Paxlovid, short of analysts' expectation of USD 10.33 billion
Read More
No Covid Test Requirements For Pfizer, Merck Pills: USFDA
The health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result
Read More
Pfizer To Sell All Its Drugs At Non-profit Price In Low-income Countries
n an expansion of the company's "An Accord for a Healthier World" program, which is aimed at increasing access to innovative treatments in some of the world's poorest countries, Pfizer said it will now offer a total of 500 products
Read More
Pfizer's Covid Drug Paxlovid Difficult To Get In China
Chinese authorities have acknowledged that supplies of Paxlovid are still insufficient to meet demand, even as Pfizer CEO Albert Bourla said last week that thousands of courses of the treatment were shipped to the country last year and in the past couple of weeks millions more were shipped
Read More
Early Signal Of Linkage Between Pfizer Bivalent Covid Shot & Stroke Seen By USFDA, CDC
The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said on Friday that a CDC vaccine database had uncovered a possible safety issue in which people 65 and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech biv
Read More
Pfizer To Explore Options Regarding Rare Disease, Cancer Drugs
Pfizer now plans to focus on internally developing rare disease treatments using technologies such as gene editing, it said, while exploring external opportunities for early-stage gene therapy programs and its cancer-focused research facility in Boulder, Colorado
Read More
Pfizer's Hemophilia B Gene Therapy Pass The Late-Stage Study
Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, as opposed to current treatments, which focus on regular infusions of the protein
Read More
Pfizer Wins Race-bias Lawsuit On Minority Fellowship Program
The lawsuit was filed in September, a month before the U.S. Supreme Court heard arguments in a pair of cases against Harvard University and the University of North Carolina that could determine the future of affirmative action in higher education
Read More